Vertex Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
VRTX News
Loading... Loading... Vertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending...
With its stock down 7.5% over the past three months, it is easy to disregard Vertex Pharmaceuticals (NASDAQ:VRTX). However, stock prices are usually driven by a...
Vertex Pharmaceuticals announced that the European Commission has granted approval for the label expansion of KALYDECO for the treatment of infants down to 1 mo...
Analyst ratings
62%
of 34 ratingsMore VRTX News
- KALYDECO ® is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the...
Print this page So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some...
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the previous trading session. The stock's change was less than t...
Loading... Loading... Vertex Pharmaceuticals's VRTX short percent of float has fallen 3.75% since its last report. The company recently reported that it has 3....
Bill Oxford Buying companies with breakthrough science or technologies can be difficult as their stock is often priced highly with respect to its revenues, ear...
Vertex Pharmaceuticals Incorporated VRTX announced that it has entered into a licensing and collaboration agreement with France-based biotech company, TreeFrog...
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in bill...
